Imagine a transmembrane molecule that lies in the plasma membrane and acts as a receptor for an extracellular signaling molecule. When the ligand-binding domain is inserted into the er during synthesis of this transmembrane molecule, will it lie on the lumen side of the er or the cytoplasm side?.